Display options
Cite
Rao R, Ss S, Shenoy V, et al. Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation. J Clin Diagn Res. 2015;9(10):XC08-XC12doi: 10.7860/JCDR/2015/12191.6671.
Rao, R., Ss, S., Shenoy, V., Hegde, M. C., Prasad, V., & Prasad, K. (2015). Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation. Journal of clinical and diagnostic research : JCDR, 9(10), XC08-XC12. https://doi.org/10.7860/JCDR/2015/12191.6671
Rao, Raghavendra, et al. "Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation." Journal of clinical and diagnostic research : JCDR vol. 9,10 (2015): XC08-XC12. doi: https://doi.org/10.7860/JCDR/2015/12191.6671
Rao R, Ss S, Shenoy V, Hegde MC, Prasad V, Prasad K. Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation. J Clin Diagn Res. 2015 Oct;9(10):XC08-XC12. doi: 10.7860/JCDR/2015/12191.6671. Epub 2015 Oct 01. PMID: 26557601; PMCID: PMC4625320.
Copy Download .nbib Format: NLM
Share it on

J Clin Diagn Res. 2015 Oct;9(10):XC08-XC12. doi: 10.7860/JCDR/2015/12191.6671. Epub 2015 Oct 01.

Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation.

Journal of clinical and diagnostic research : JCDR

Raghavendra Rao, Suhas Ss, Vijendra Shenoy, Mahesh Chandra Hegde, Vishnu Prasad, Krishna Prasad

Affiliations

  1. Associate Professor, Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Manipal University , Mangalore, Karnataka, India .
  2. Junior Resident, Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Manipal University , Mangalore, Karnataka, India .
  3. Professor, Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Manipal University , Mangalore, Karnataka, India .
  4. Senior Resident, Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Manipal University , Mangalore, Karnataka, India .
  5. Associate Professor, Department of Medical Oncology, Kasturba Medical College, Manipal University , Mangalore, Karnataka, India .

PMID: 26557601 PMCID: PMC4625320 DOI: 10.7860/JCDR/2015/12191.6671

Abstract

BACKGROUND: Considering the uprising number of Head and neck cancer in the state with limited options of medical and surgical treatment, the focus of this study involved on chemotherapy in advanced Head and neck cancers. The aim of this study was to evaluate the efficacy and toxicity of combination of Cisplatin and 5-Fluorouracil (PF) as induction chemotherapy in patients in locally advanced squamous cell cancer of head and neck.

MATERIALS AND METHODS: Forty four patients with previously untreated stage III -IV advanced and inoperable cases were included in this prospective study. Induction chemotherapy consisted of 3 cycles of Cisplatin 100mg/mt(2) as infusion on day 1, 5-Fluorouracil of 750mg/mt(2) on day 2, 5-Fluorouracil of 1000mg/mt2 as infusion on day 3 in an inpatient basis. Cycles were repeated with an interval of 21 days. Patients were evaluated within a period of 3 weeks at the end of completion of third cycle of chemotherapy. Post chemotherapy local therapy was individualized based on the response, site and stage of the tumour.

RESULTS: Out of 44 eligible and evaluable patients, major dominance was noted in male group constituting 68%. After induction chemotherapy 58.8% of stage III experienced stable response, & 44% had partial response. In stage IV, 44% showed a stable response and 33.3% had partial response. But in comparison to primary tumour response and nodal response, which had a significant clinical response, the overall response of malignancy with respect to stage and site specificity was clinically insignificant. Moderate adverse reaction was noted in 47.6% and 42.1% had mild reactions. Majority of patients experienced grade 3 adverse events, of which anaemia in females and leucopenia in males pre-dominated.

CONCLUSION: With the use of cisplatin and 5-FU as induction chemotherapy agents in advanced and inoperable squamous cell carcinoma of head and neck, a distinct benefit was seen in stabilizing the tumour from progression. But achieving a significant complete response to the same is of faint possibility. An alternate multidrug regimen or multimodality treatment would be ideal to gain the optimum results from induction agents. Toxicity related to chemotherapy usually is transient at therapeutic doses, and can be controlled by adequate prophylactic measures.

Keywords: Adverse effects; Squamous cell carcinoma of head and neck (SCCHN); Tumour response

References

  1. J Natl Cancer Inst. 1996 May 1;88(9):583-9 - PubMed
  2. Lancet. 2000 Mar 18;355(9208):949-55 - PubMed
  3. J Natl Cancer Inst. 2009 Apr 1;101(7):498-506 - PubMed
  4. N Engl J Med. 2007 Oct 25;357(17):1695-704 - PubMed
  5. N Engl J Med. 2007 Oct 25;357(17):1705-15 - PubMed
  6. Ann Oncol. 2004 Apr;15(4):638-45 - PubMed
  7. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81 - PubMed
  8. Eur J Cancer. 2009 Jan;45(2):228-47 - PubMed
  9. Cancer. 1987 Sep 15;60(6):1178-83 - PubMed
  10. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  11. J Natl Cancer Inst. 1994 Feb 16;86(4):265-72 - PubMed

Publication Types